217 tracked 13F filers disclose a position in QURE as of the latest SEC 13F filings, a combined $1.7B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Avoro Capital Advisors LLC | $309.9M | 6.7M | ▲+13% Added · +768K sh | Q2 2026 | |
| 2 | Aberdeen Group plc | $86.8M | 5.3M | ▲+44% Added · +1.6M sh | Q1 2026 | |
| 3 | RTW INVESTMENTS, LP | $181.5M | 3.9M | ▲+52% Added · +1.4M sh | Q2 2026 | |
| 4 | STATE STREET CORP | $133.8M | 2.9M | ▲+28% Added · +643K sh | Q2 2026 | |
| 5 | JPMORGAN CHASE & CO | $41.8M | 2.8M | ▼−3.3% Reduced · −97K sh | Q1 2026 | |
| 6 | TWO SIGMA INVESTMENTS, LP | $43.8M | 2.7M | ▲+84% Added · +1.2M sh | Q1 2026 | |
| 7 | ORBIMED ADVISORS LLC | $34.9M | 2.1M | ▲+190% Added · +1.4M sh | Q1 2026 | |
| 8 | FMR LLC | $28.5M | 1.7M | ▼−72% Reduced · −4.5M sh | Q1 2026 | |
| 9 | BlackRock, Inc. | $28.3M | 1.7M | ▼−12% Reduced · −242K sh | Q1 2026 | |
| 10 | MPM BioImpact LLC | $22.4M | 1.4M | ▼−0.9% Reduced · −12K sh | Q1 2026 | |
| 11 | Two Seas Capital LP | $21.3M | 1.3M | ▲New +1.3M sh | Q1 2026 | |
| 12 | GOLDMAN SACHS GROUP INC | $20.7M | 1.3M | ▲+8.2% Added · +96K sh | Q1 2026 | |
| 13 | JENNISON ASSOCIATES LLC | $20.2M | 1.2M | ▼−10% Reduced · −137K sh | Q1 2026 | |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16.4M | 1.0M | ▼−18% Reduced · −216K sh | Q1 2026 | |
| 15 | BALYASNY ASSET MANAGEMENT L.P. | $15.8M | 964K | ▲+611% Added · +829K sh | Q1 2026 | |
| 16 | MAVERICK CAPITAL LTD | $42.6M | 925K | ▲+33% Added · +228K sh | Q2 2026 | |
| 17 | CITADEL ADVISORS LLC | $41.9M | 910K | ▲+125% Added · +506K sh | Q2 2026 | |
| 18 | Fiera Capital Corp | $41.9M | 909K | ▲+11% Added · +92K sh | Q2 2026 | |
| 19 | Integral Health Asset Management, LLC | $41.5M | 900K | —Held | Q2 2026 | |
| 20 | GEODE CAPITAL MANAGEMENT, LLC | $39.7M | 861K | ▲+7.0% Added · +56K sh | Q2 2026 | |
| 21 | MILLENNIUM MANAGEMENT LLC | $13.0M | 793K | ▼−1.4% Reduced · −11K sh | Q1 2026 | |
| 22 | VANGUARD CAPITAL MANAGEMENT LLC | $11.4M | 695K | →First observed position No prior filed position | Q1 2026 | |
| 23 | Boxer Capital Management, LLC | $10.8M | 662K | ▲+128% Added · +372K sh | Q1 2026 | |
| 24 | JANE STREET GROUP, LLC | $10.4M | 636K | ▲Added Added · +636K sh | Q1 2026 | |
| 25 | First Turn Management, LLC | $28.0M | 609K | ▼−1.1% Reduced · −7K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 9 funds opened a new position in QURE and 31 added to an existing one, while 18 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| AMAZON.COM INCAMZN | 112 funds | $106.7B |
| MICROSOFT CORPMSFT | 108 funds | $143.6B |
| NVIDIA CORPNVDA | 106 funds | $214.2B |
| ALPHABET INC-CL AGOOGL | 104 funds | $90.2B |
| META PLATFORMS INC-CLASS AMETA | 104 funds | $61.8B |
| MICRON TECHNOLOGY INCMU | 103 funds | $21.0B |
| ELI LILLY & COLLY | 102 funds | $44.0B |
| APPLE INCAAPL | 99 funds | $158.7B |
| ADVANCED MICRO DEVICESAMD | 99 funds | $22.7B |
| ORACLE CORPORCL | 99 funds | $13.3B |
| BROADCOM INCAVGO | 98 funds | $88.2B |
| ALPHABET INC-CL CGOOG | 97 funds | $64.8B |
Ranked by how many of QURE's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 2, 2026 | Kapusta Matthew C | CEO, Managing Director, Director | Sell (S) | 9K | $409K |
| Jul 2, 2026 | Kapusta Matthew C | CEO, Managing Director, Director | Sell (S) | 4K | $195K |
| Jul 2, 2026 | Kapusta Matthew C | CEO, Managing Director, Director | Sell (S) | 8K | $349K |
| Jun 30, 2026 | Abi-Saab Walid | Chief Medical Officer | Sell (S) | 10K | $465K |
| Jun 30, 2026 | Abi-Saab Walid | Chief Medical Officer | Sell (S) | 20K | $928K |
| Jun 30, 2026 | Kaye Jack | Director | Sell (S) | 4K | $191K |
| Jun 30, 2026 | Kaye Jack | Director | Sell (S) | 17K | $792K |
| Jun 26, 2026 | Abi-Saab Walid | Chief Medical Officer | Sell (S) | 1K | $67K |
| Jun 25, 2026 | Kapusta Matthew C | CEO, Managing Director, Director | Sell (S) | 29K | $1.4M |
| Jun 24, 2026 | Kapusta Matthew C | CEO, Managing Director, Director | Sell (S) | 7K | $335K |
| Jun 18, 2026 | Kapusta Matthew C | CEO, Managing Director, Director | Sell (S) | 5K | $233K |
| Jun 18, 2026 | Kapusta Matthew C | CEO, Managing Director, Director | Sell (S) | 37K | $1.9M |
Connected entities for QURE
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/QURE/capital-change-brief"
Use Arkolith's capital_change_brief for QURE. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for QURE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.